There is a newer version of the record available.

Published October 30, 2024 | Version v1
Other Open

In Silico Trials: An updated SWOT Analysis

  • 1. IRCCS Istituto Ortopedico Rizzoli
  • 2. Università degli Studi di Bologna
  • 1. University of Catania
  • 2. InSilicoTrials Technologies SpA, Trieste, Italy

Description

The targets of this document are the executives of biomedical companies, large and small, who must decide if, when, and how much to invest in In Silico Trials. By providing them with a thorough, well-documented SWOT analysis, we aim to facilitate this task and favour more extensive investments toward their adoption.

Files

In Silico World - In Silico Trials SWOT Analysis.pdf

Files (1.4 MB)

Additional details

Funding

European Commission
ISW - In Silico World: Lowering barriers to ubiquitous adoption of In Silico Trials 101016503

Dates

Created
2024-10-14